Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.

Kats, Lev M; Reschke, Markus; Taulli, Riccardo; Pozdnyakova, Olga; Burgess, Kerri; Bhargava, Parul; Straley, Kimberly; Karnik, Rahul; Meissner, Alexander; Small, Donald; Su, Shinsan M; Yen, Katharine; Zhang, Jiangwen; Pandolfi, Pier Paolo

Kats, Lev M; Reschke, Markus; Taulli, Riccardo; Pozdnyakova, Olga; Burgess, Kerri; Bhargava, Parul; Straley, Kimberly; Karnik, Rahul; Meissner, Alexander; Small, Donald; Su, Shinsan M; Yen, Katharine; Zhang, Jiangwen; Pandolfi, Pier Paolo.

Affiliation

Kats LM; Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Reschke M; Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Taulli R; Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
Burgess K; Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Bhargava P; Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Straley K; Agios Pharmaceuticals, Cambridge, MA 02139, USA.
Karnik R; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
Meissner A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
Small D; Oncology and Pediatrics, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Su SM; Agios Pharmaceuticals, Cambridge, MA 02139, USA.
Yen K; Agios Pharmaceuticals, Cambridge, MA 02139, USA.
Zhang J; School of Biological Sciences, The University of Hong Kong, Hong Kong SAR.
Pandolfi PP; Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address: ppandolf@bidmc.harvard.edu.

Cell Stem Cell ; 14(3): 329-41, 2014 Mar 06.

Article de En | MEDLINE | ID: mdl-24440599

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oncogènes / Leucémie aigüe myéloïde / Carcinogenèse / Isocitrate dehydrogenases / Mutation Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Cell Stem Cell Année: 2014 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google